Evidence‐based recommendation (3.8)
In regenerative therapy, we recommend the use of either barrier membranes or enamel matrix derivative with or without the addition of bone‐derived grafts*
Supporting literature Nibali et al. (2019)
Quality of evidence Twenty RCTs (972 patients)—four studies at low risk of bias—moderate‐to‐high heterogeneity for superiority of these biomaterials
Grade of recommendation Grade A—↑↑
Strength of consensus Consensus (18.1% of the group abstained due to potential CoI)